Abstract
Atopic dermatitis (AD), characterized by skin barrier dysfunction and inflammation, is associated with food allergy and asthma development. Underlying mechanisms for disease co-expression remain poorly understood. The skin microbiome’s role in modulating skin disorders, including AD, and systemic immunity is still under investigation. We hypothesize that metabolic output of skin-associated bacteria in AD contributes to barrier dysfunction and the atopic march.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
